On August 30, 2023 RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in inflammatory diseases and oncology, reported that members of the RAPT management team will participate in the following investor conferences in September (Press release, RAPT Therapeutics, AUG 30, 2023, https://investors.rapt.com/news-releases/news-release-details/rapt-therapeutics-participate-several-upcoming-investor-2 [SID1234634776]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2023 Healthcare Conference – Fireside chat on Wednesday, September 6, 2023 at 8:00 a.m. ET

H.C. Wainwright 25th Annual Global Investment Conference – Presentation on Monday, September 11, 2023 at 2:00 p.m. ET

Stifel 2023 Immunology and Inflammation Virtual Summit – Fireside chat on Tuesday, September 19, 2023 at 3:45 p.m. ET

Cantor Global Healthcare Conference – Presentation on Tuesday, September 26, 2023 at 10:35 a.m. ET
To access the available live webcasts or subsequent archived recordings of the discussions and presentations, please visit the RAPT Therapeutics website at https://investors.rapt.com/events-and-presentations.